K Roholt
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Microbial Natural Products and Biosynthesis
Papers in
- Pharmacology 13
- Antibiotics Pharmacokinetics and Efficacy 9
- Drug-Induced Adverse Reactions 4
-
- Phenothiazines and Benzothiazines Synthesis and Activities 3
- Co-authors
- L. Tybring (6 shared papers)W. O. Godtfredsen (5 shared papers)H Schmidt (3 shared papers)F Lund (3 shared papers)Hans J. Petersen (1 shared paper)Ellids Kristensen (2 shared papers)B Nielsen (2 shared papers)W. von Daehne (1 shared paper)
In The Last Decade
K Roholt
23 papers receiving 631 citations
Peers
Comparison fields: 5 of 98
- Molecular Medicine 85
- Pharmacology 269
- Applied Microbiology and Biotechnology 16
- Infectious Diseases 131
- Pharmacology 61
Countries citing papers authored by K Roholt
This map shows the geographic impact of K Roholt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Roholt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Roholt more than expected).
Fields of papers citing papers by K Roholt
This network shows the impact of papers produced by K Roholt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Roholt. The network helps show where K Roholt may publish in the future.
Co-authors
The 16 scholars most cited alongside K Roholt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1962 | 183 | |
| 2 | 1970 | 139 | |
| 3 | 1962 | 133 | |
| 4 | Pivampicillin, a new orally active ampicillin ester. | 1970 | 54 |
| 5 | 1974 | 38 | |
| 6 | 1977 | 38 | |
| 7 | 1973 | 35 | |
| 8 | 1966 | 31 | |
| 9 | 1971 | 30 | |
| 10 | 1951 | 12 | |
| 11 | [Investigations of the penicillin concentration in the serum following benzyl penicillin sodium in massive doses. With reference to the treatment of gonorrhea in Greenland]. | 1965 | 10 |
| 12 | [Pivampicillin chloride--a new broad-spectrum antibiotic for oral use]. | 1971 | 9 |
| 13 | 2009 | 8 | |
| 14 | 1976 | 6 | |
| 15 | 1967 | 4 | |
| 16 | 1952 | 4 | |
| 17 | 1953 | 4 | |
| 18 | [Fucidin, a new antibiotic for peroral therapy]. | 1962 | 4 |
| 19 | [Calcipen Leo, a new peroral penicillin preparation]. | 1956 | 4 |
| 20 | 1963 | 3 |
About K Roholt
K Roholt is a scholar working on Pharmacology, Molecular Biology, Organic Chemistry, Epidemiology and Infectious Diseases, having authored 23 papers that have together received 754 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Drug-Induced Adverse Reactions (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Drug Transport and Resistance Mechanisms (2 papers), HIV/AIDS drug development and treatment (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Synthesis of β-Lactam Compounds (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Molecular Medicine (85 citations), Pharmacology (269 citations), Applied Microbiology and Biotechnology (16 citations), Infectious Diseases (131 citations) and Pharmacology (61 citations). K Roholt has collaborated with scholars based in Denmark and Australia. Frequent co-authors include L. Tybring, W. O. Godtfredsen, H Schmidt, F Lund, Hans J. Petersen, Ellids Kristensen, B Nielsen, W. von Daehne, Henrik Toft Sørensen and Peter W. Feit. Their work appears in journals such as Journal of Pharmacy and Pharmacology, Scandinavian Journal of Clinical and Laboratory Investigation, The Journal of Antibiotics, Antimicrobial Agents and Chemotherapy and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.